← Evidence map

ArticleCancer research communications2024

Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials.

Esther J Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39099199